DaVita(DVA)
Search documents
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks Investment Research· 2024-04-18 23:06
DaVita HealthCare (DVA) closed at $126.11 in the latest trading session, marking a -1.2% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.22% for the day. At the same time, the Dow added 0.06%, and the tech-heavy Nasdaq lost 0.52%.Coming into today, shares of the kidney dialysis provider had lost 8.03% in the past month. In that same time, the Medical sector lost 6.22%, while the S&P 500 lost 1.66%.Investors will be eagerly watching for the performance of DaVita Hea ...
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call
Prnewswire· 2024-04-17 23:31
DENVER, April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Thursday, May 2, 2024Starting at 5:00 p.m. EDTWebcast can be accessed using this link Dial in number: 877-918-6 ...
Market Jitters: 2 Top Ranked Stocks for Defensive Positioning
Zacks Investment Research· 2024-04-10 19:46
Just this morning, the CPI data reported a notable and surprise increase in the rate of inflation. Although disinflationary pressure have been strong since early 2023, it seems those forces have reversed, and policymakers may have to deal with the changing expectations.Because of this reversal in disinflation, the market expectations for a rate cut have fallen, and futures markets are now pricing in just two rate cuts starting in September, from three cuts starting in June. It is a pretty significant shift ...
Here's Why You Should Add DaVita (DVA) to Your Portfolio
Zacks Investment Research· 2024-04-10 18:36
DaVita Inc. (DVA) has been gaining from its business model. The optimism led by a solid fourth-quarter 2023 performance and the acquisition of dialysis centers are expected to contribute further. However, concerns regarding its dependence on commercial payers and macroeconomic challenges persist.Over the past year, this Zacks Rank #1 (Strong Buy) stock has gained 57.8% compared with a 15.7% rise of the industry and 27.4% growth of the S&P 500.The renowned global comprehensive kidney care provider has a mark ...
Is Most-Watched Stock DaVita Inc. (DVA) Worth Betting on Now?
Zacks Investment Research· 2024-04-10 14:06
DaVita HealthCare (DVA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this kidney dialysis provider have returned -3.7% over the past month versus the Zacks S&P 500 composite's +1.8% change. The Zacks Medical - Outpatient and Home Healthcare industry, to which DaVita HealthCare belongs, has lost 0.8% over this period. Now the key question is: Where coul ...
DaVita Announces Dennis Pullin to its Board of Directors
Prnewswire· 2024-04-10 13:00
DENVER, April 10, 2024 /PRNewswire/ -- DaVita Inc. today announced that its Board of Directors has appointed a new independent director, Dennis Pullin, to join the Board, effective April 10, 2024."We're pleased to welcome Dennis to DaVita's board," said Pamela Arway, independent chair of the DaVita Inc. Board of Directors. "Given his depth of experience within the healthcare system, we're excited about the perspective Dennis will bring to the Board and look forward to his positive impact on our future growt ...
Why the Market Dipped But DaVita HealthCare (DVA) Gained Today
Zacks Investment Research· 2024-04-08 23:06
DaVita HealthCare (DVA) ended the recent trading session at $133.73, demonstrating a +0.09% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of 0.04%. On the other hand, the Dow registered a loss of 0.03%, and the technology-centric Nasdaq increased by 0.03%.Shares of the kidney dialysis provider have depreciated by 1.15% over the course of the past month, underperforming the Medical sector's loss of 0.6% and the S&P 500's gain of 2.57%.Market participa ...
Diagnosing the Economy Ahead of World Health Day: 6 Picks
Zacks Investment Research· 2024-04-05 13:16
After wrapping up a robust first quarter on strong corporate profits, enthusiasm around AI and hopes that the Fed will cut rates, Wall Street’s rally fizzled out to start Q2 on uncertainty over the timing of rate cuts.Let us examine the health of the U.S. economy ahead on the World Health Day and bring to investors’ attention the key developments and some solid picks for a robust investment portfolio.Similar to the six vital nutrients required for good health, six pillars support the economy. Here, we have ...
DaVita HealthCare (DVA) Is Up 1.09% in One Week: What You Should Know
Zacks Investment Research· 2024-03-21 15:46
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...
4 Stocks Trading Near 52-Week High That Can Climb Further
Zacks Investment Research· 2024-03-21 13:21
Stocks hitting their 52-week high and delivering consistent performance offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived to be winners. However, stocks touching a new 52-week high are often predisposed to profit-taking, resulting in pullbacks and trend reversals.Moreover, given the high price, investors often wonder if the stock is overpriced. While the speculations are not absolutely baseless, all stocks hitting a 52-week high are ...